Precision Compounding Pharmacy, a NYC-based technology-enabled compounding pharmacy company, received a seed investment from Right Side Capital Management.
The amount of the deal was not disclosed.
The company intends to use the funds to enhance its suite of services, broaden its reach, and drive innovation in the pharmacy industry.
Led by CEO Christian Stella, Precision Compounding Pharmacy is a tech-enabled compounding pharmacy that supports the fulfillment of prescriptions for telemedicine companies. PCP is licensed in 44 states with two locations, New York and Florida. It acts as a backend center by sending API transactions to partner telemedicine companies for prescription updates.
The company is licensed in 44 states and has two physical locations in New York and Florida.
